How quickly does Wegovy start working after injection?

Does Wegovy do anything after the very first injection?

Yes, semaglutide is pharmacologically active from the first dose, even at 0.25 mg. It binds to GLP-1 receptors in the brain and gut, slowing how quickly the stomach empties and signalling to the brain that fullness has arrived sooner than usual. Some people report noticeably smaller appetite within three to five days of that first pen. Others feel little different for two or three weeks.

The spread is real, and it matters. Body weight, metabolic rate, gut transit time and previous eating patterns all influence how quickly those signals translate into a different pattern at the table. So comparing your week-two experience with someone else's isn't particularly useful.

What the first pen is definitively not designed to do is produce rapid weight loss. The starter dose exists to let your body adjust to the medicine before the therapeutic dose is reached, the emphasis is on tolerability, not speed. Trying to push the dose faster than the licensed schedule to get quicker results is not clinically appropriate and requires discussion with a prescriber.

If you want to understand how soon after a Wegovy injection the medicine begins to take effect, that page walks through what happens in the body from the moment you inject. For a closer look at the very first hours and days after an injection, our page on how long after a Wegovy injection it starts working covers the pharmacokinetic detail.

When do most people start losing weight on Wegovy?

Measurable weight loss (enough to show on a reliable set of scales) tends to appear between weeks four and eight for most people. By that point they have usually completed at least one or two dose steps and the appetite effect is more sustained throughout the week.

The STEP 1 trial, published in the New England Journal of Medicine, followed nearly 2,000 adults on semaglutide 2.4 mg over 68 weeks and recorded an average body-weight reduction of around 15%. That average was reached cumulatively: steady losses each month, not a dramatic drop early on. Weight loss continued to accumulate well past the twelve-week mark for most participants.

Two practical patterns people describe: the first few weeks often feel like reduced hunger without the scales moving much; then, as the body draws on stored energy, the numbers start to shift. Fluid changes in the first fortnight can also muddy the picture, genuine fat loss is slower and steadier.

Consistency matters here. Wegovy is taken once a week on the same day, and missing injections or storing pens incorrectly can affect how reliably levels stay stable. If you're uncertain whether your pen is functioning as expected, our guide on what to do if your Wegovy pen doesn't seem to be working addresses the most common causes.

Why does it take months to reach the maintenance dose, and does that slow things down?

The dose titration (0.25 mg for four weeks, then 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg, each held for roughly four weeks) is set by the licensed schedule for a reason. Moving too quickly significantly increases the likelihood of nausea, vomiting and other gastrointestinal effects that make treatment unsustainable.

That does mean full therapeutic effect arrives later. The 2.4 mg maintenance dose is where the strongest appetite reduction occurs, and most participants in clinical trials reached it around week seventeen. The weight loss that accumulates before that point is genuine, but the steeper trajectory tends to start once maintenance is reached.

For people curious about how Wegovy compares with tirzepatide, which operates via two gut-hormone receptors rather than one, our Wegovy overview page sets out the evidence side by side. The weight-loss treatment options page covers the broader picture if you're still deciding between approaches.

One important note: NICE recommends reviewing continuation if less than 5% weight loss has occurred after six months at the maintenance dose. That assessment is a clinical one, made by a prescriber, not a reason to stop early or to panic if progress feels slow in the opening weeks. The NICE appraisal of semaglutide (TA875) is the basis for how UK clinicians approach these decisions.

Is there anything that affects how quickly Wegovy works for you specifically?

Several factors influence individual response, and none of them are fully predictable from the outside.

Starting BMI plays a role, people with higher BMIs often see larger absolute weight changes but sometimes a slightly slower percentage response early on. Prior use of other GLP-1 medicines can affect the baseline too. Dietary pattern matters: semaglutide reduces appetite but does not override calorie intake entirely, so what you eat alongside it shapes the outcome. Physical activity influences the rate at which weight shifts and, crucially, whether the loss is fat rather than muscle.

GI side effects in the early weeks can themselves affect food intake, sometimes more sharply than the medicine's direct appetite effect. Nausea that makes eating difficult is not the same mechanism as therapeutic appetite reduction, and it usually settles. Protein intake and hydration often become more important during this period.

If you're comparing notes with other people who've injected semaglutide under different brand names, it's worth knowing that Ozempic contains the same active ingredient but is licensed for type 2 diabetes, not weight loss, the doses and treatment goals differ. For a clear comparison of what the evidence says about timing and results across weight-loss injections, the detailed timeline page goes further into the week-by-week picture.

Thinking about starting Wegovy through a regulated UK pharmacy? Our prescribers review every consultation the same day it's submitted. Check your eligibility here.